BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34341171)

  • 1. MicroRNA-21 Deficiency Promotes the Early Th1 Immune Response and Resistance toward Visceral Leishmaniasis.
    Varikuti S; Verma C; Holcomb E; Jha BK; Viana A; Maryala R; Lamenza F; McElwain BK; Doni NY; Papenfuss T; Oghumu S; Gannavaram S; Nakhasi HL; Satoskar AR
    J Immunol; 2021 Sep; 207(5):1322-1332. PubMed ID: 34341171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani.
    Terrazas C; Varikuti S; Kimble J; Moretti E; Boyaka PN; Satoskar AR
    FASEB J; 2016 Mar; 30(3):1135-43. PubMed ID: 26581600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
    Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA 155 Contributes to Host Immunity against Leishmania donovani but Is Not Essential for Resolution of Infection.
    Varikuti S; Natarajan G; Volpedo G; Singh B; Hamza O; Messick GV; Guerau-de-Arellano M; Papenfuss TL; Oghumu S; Satoskar AR
    Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31182615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.
    Rostan O; Gangneux JP; Piquet-Pellorce C; Manuel C; McKenzie AN; Guiguen C; Samson M; Robert-Gangneux F
    mBio; 2013 Sep; 4(5):e00383-13. PubMed ID: 24045639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-21 Expression Determines the Early Vaccine Immunity Induced by
    Gannavaram S; Bhattacharya P; Siddiqui A; Ismail N; Madhavan S; Nakhasi HL
    Front Immunol; 2019; 10():2273. PubMed ID: 31608064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live Attenuated
    Banerjee A; Bhattacharya P; Dagur PK; Karmakar S; Ismail N; Joshi AB; Akue AD; KuKuruga M; McCoy JP; Dey R; Nakhasi HL
    J Immunol; 2018 Jan; 200(1):163-176. PubMed ID: 29187586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
    Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
    Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
    Choudhury R; Das P; De T; Chakraborti T
    Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
    Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
    J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-33/ST2 axis is involved in disease progression in the spleen during Leishmania donovani infection.
    Lamberet A; Rostan O; Dion S; Jan A; Guegan H; Manuel C; Samson M; Gangneux JP; Robert-Gangneux F
    Parasit Vectors; 2020 Jun; 13(1):320. PubMed ID: 32571430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis.
    Nico D; Martins Almeida F; Maria Motta J; Soares Dos Santos Cardoso F; Freire-de-Lima CG; Freire-de-Lima L; de Luca PM; Maria Blanco Martinez A; Morrot A; Palatnik-de-Sousa CB
    Front Immunol; 2018; 9():967. PubMed ID: 29867949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Induction of SOCS Isoforms by
    Chandrakar P; Parmar N; Descoteaux A; Kar S
    J Immunol; 2020 Feb; 204(3):596-610. PubMed ID: 31882519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.
    Basu R; Bhaumik S; Haldar AK; Naskar K; De T; Dana SK; Walden P; Roy S
    Infect Immun; 2007 Dec; 75(12):5956-66. PubMed ID: 17908806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani.
    McFarlane E; Perez C; Charmoy M; Allenbach C; Carter KC; Alexander J; Tacchini-Cottier F
    Infect Immun; 2008 Feb; 76(2):532-41. PubMed ID: 18056477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides.
    Agallou M; Pantazi E; Tsiftsaki E; Toubanaki DK; Gaitanaki C; Smirlis D; Karagouni E
    Mol Immunol; 2018 Nov; 103():7-20. PubMed ID: 30173073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ly6C
    Terrazas C; Varikuti S; Oghumu S; Steinkamp HM; Ardic N; Kimble J; Nakhasi H; Satoskar AR
    Sci Rep; 2017 Oct; 7(1):14693. PubMed ID: 29089636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
    Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
    Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
    Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
    J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12 enhances Th1-type responses in human Leishmania donovani infections.
    Ghalib HW; Whittle JA; Kubin M; Hashim FA; el-Hassan AM; Grabstein KH; Trinchieri G; Reed SG
    J Immunol; 1995 May; 154(9):4623-9. PubMed ID: 7722314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.